-
公开(公告)号:US20080027058A1
公开(公告)日:2008-01-31
申请号:US11630224
申请日:2005-06-27
申请人: Paul Coleman , Christopher Cox , Mark Fraley , George Hartman , John Schreier
发明人: Paul Coleman , Christopher Cox , Mark Fraley , George Hartman , John Schreier
IPC分类号: A61K31/4155 , A61K31/454 , A61K31/496 , A61P35/00 , C07D401/06 , C07D403/06 , C07D413/06 , C07D417/06
CPC分类号: C07D231/12 , C07D401/06 , C07D401/14 , C07D403/06 , C07D403/12 , C07D403/14 , C07D413/14 , C07D487/08 , C07D491/107 , C07D491/113
摘要: The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
-
公开(公告)号:US20060100191A1
公开(公告)日:2006-05-11
申请号:US10531495
申请日:2003-10-14
IPC分类号: A61K31/5377 , A61K31/454 , A61K31/4025 , A61K31/401 , C07D413/02 , C07D403/02
CPC分类号: C07D405/12 , C07D207/20 , C07D401/12 , C07D401/14 , C07D403/12
摘要: The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
-
公开(公告)号:US20050228003A1
公开(公告)日:2005-10-13
申请号:US10497553
申请日:2002-12-02
申请人: Mark Fraley , George Hartman , William Hoffman
发明人: Mark Fraley , George Hartman , William Hoffman
IPC分类号: A61K31/138 , A61K31/337 , A61K31/4465 , A61K31/4535 , A61K31/519 , A61K31/551 , A61K31/5513 , A61K39/395 , A61K45/00 , A61P35/00 , C07D495/04 , C07D498/02 , C07D519/00
CPC分类号: C07D495/04 , C07D519/00
摘要: The present invention relates to thienopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译: 本发明涉及可用于治疗细胞增殖性疾病,用于治疗与KSP驱动蛋白活性相关的病症和用于抑制KSP驱动蛋白的噻吩并嘧啶酮化合物。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
-
公开(公告)号:US20050176737A1
公开(公告)日:2005-08-11
申请号:US10497385
申请日:2002-12-02
申请人: Mark Fraley , George Hartman , William Hoffman
发明人: Mark Fraley , George Hartman , William Hoffman
IPC分类号: A61K31/519 , A61K31/5377 , A61K31/551 , A61K31/5513 , A61K45/00 , A61P35/00 , A61P35/02 , A61P35/04 , A61P43/00 , C07D487/04 , C07D519/00 , C07D491/02 , C07D498/02
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention relates to azolopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译: 本发明涉及可用于治疗细胞增殖性疾病,用于治疗与KSP驱动蛋白活性相关的病症和用于抑制KSP驱动蛋白的偶氮嘧啶酮化合物。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
-
公开(公告)号:US20050119484A1
公开(公告)日:2005-06-02
申请号:US10506702
申请日:2003-03-04
申请人: Michael Breslin , Paul Coleman , Christopher Cox , J. christopher Culberson , George Hartman , Brenda Mariano , Maricel Torrent
发明人: Michael Breslin , Paul Coleman , Christopher Cox , J. christopher Culberson , George Hartman , Brenda Mariano , Maricel Torrent
IPC分类号: A61K31/415 , A61K31/4155 , A61K31/4178 , A61K31/4184 , A61K31/422 , A61K31/427 , A61K31/4439 , A61K31/454 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K45/00 , A61P35/00 , C07D231/06 , C07D231/14 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/04 , C07D405/12 , C07D413/04 , C07D417/04 , C07D43/02
CPC分类号: C07D401/04 , C04B35/632 , C07D231/06 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/04 , C07D405/12 , C07D413/04 , C07D417/04
摘要: The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译: 本发明涉及可用于治疗细胞增殖性疾病,治疗与KSP驱动蛋白活性相关的疾病和用于抑制KSP驱动蛋白的二氢吡唑化合物。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
-
公开(公告)号:US20050096344A1
公开(公告)日:2005-05-05
申请号:US10900662
申请日:2004-07-28
申请人: Mark Fraley , Kenneth Arrington , Mark Bilodeau , George Hartman , William Hoffman , Yuntae Kim , Randall Hungate
发明人: Mark Fraley , Kenneth Arrington , Mark Bilodeau , George Hartman , William Hoffman , Yuntae Kim , Randall Hungate
IPC分类号: A61K31/495 , A61K45/06 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/02 , A61K31/4745 , C07D491/02 , C07D498/02
CPC分类号: C07D401/14 , A61K31/495 , A61K45/06 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , A61K2300/00
摘要: The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
-
公开(公告)号:US20070129356A1
公开(公告)日:2007-06-07
申请号:US10582826
申请日:2004-12-15
申请人: Kenneth Arrington , Mark Fraley , George Hartman
发明人: Kenneth Arrington , Mark Fraley , George Hartman
IPC分类号: A61K31/541 , A61K31/5377 , A61K31/513 , C07D239/36
CPC分类号: C07D239/36
摘要: The present invention relates to 2-phenylpyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译: 本发明涉及可用于治疗细胞增殖性疾病,用于治疗与KSP驱动蛋白活性相关的病症和用于抑制KSP驱动蛋白的2-苯基嘧啶酮化合物。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
-
公开(公告)号:US20070088274A1
公开(公告)日:2007-04-19
申请号:US11517751
申请日:2006-09-08
IPC分类号: A61M5/178
CPC分类号: A61B17/3421 , A61B17/3423 , A61B17/3474 , A61B2017/00265 , A61B2090/064 , A61M37/00
摘要: A trocar assembly for use in surgery in a patient, comprising an elongated outer tubular member having a first or proximal end and a second or distal end. The proximal end has a housing enclosing a fluid pressure chamber therein. The distal end of the outer tubular member has a gaseous fluid discharge arrangement therethrough, through which a medical instrument is disposed for surgical manipulation of the patient.
-
公开(公告)号:US20060234984A1
公开(公告)日:2006-10-19
申请号:US10567676
申请日:2004-08-11
IPC分类号: A61K31/454 , A61K31/675 , C07D403/02
CPC分类号: C04B35/632 , C07D401/12 , C07D401/14 , C07D413/14 , C07D417/14
摘要: The present invention relates to dihydropyrrole compounds of Formula (I) that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译: 本发明涉及可用于治疗细胞增殖性疾病,用于治疗与KSP驱动蛋白活性相关的病症和用于抑制KSP驱动蛋白的式(I)的二氢吡咯化合物。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
-
公开(公告)号:US20050234080A1
公开(公告)日:2005-10-20
申请号:US10515285
申请日:2003-05-19
申请人: Paul Coleman , George Hartman , Lou Neilson
发明人: Paul Coleman , George Hartman , Lou Neilson
IPC分类号: A61K31/138 , A61K31/337 , A61K31/4465 , A61K31/513 , A61K31/5377 , A61K31/551 , A61K39/395 , A61K45/00 , A61P35/00 , C07D239/36 , C07D239/52 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/12 , C07D403/14 , C07D413/14 , C07D417/14
CPC分类号: C07D239/36 , C07D239/52 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/06 , C07D403/14 , C07D413/14 , C07D417/14
摘要: The present invention relates to dihydropyrimidone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
摘要翻译: 本发明涉及可用于治疗细胞增殖性疾病,用于治疗与KSP驱动蛋白活性相关的病症和用于抑制KSP驱动蛋白的二氢嘧啶酮化合物。 本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
-
-
-
-
-
-
-
-
-